BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36082824)

  • 1. Epidemiology and treatment outcomes of cutaneous squamous cell carcinoma extending to the temporal bone.
    Schachtel MJC; Gandhi M; Bowman JJ; Porceddu SV; Panizza BJ
    Head Neck; 2022 Dec; 44(12):2727-2743. PubMed ID: 36082824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of spread and anatomical prognostic factors of pre-auricular cutaneous squamous cell carcinoma extending to the temporal bone.
    Schachtel MJC; Gandhi M; Bowman JJ; Panizza BJ
    Head Neck; 2023 Nov; 45(11):2893-2906. PubMed ID: 37737376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral temporal bone resections for peri-auricular cutaneous squamous cell carcinoma: prognostic indicators and radiological predictive values.
    Kwok MMK; Choong KWK; Virk J; Kleid S; Magarey MJR
    J Laryngol Otol; 2022 Apr; 136(4):297-303. PubMed ID: 34819182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancies requiring temporal bone resection: An Australian single-institution experience.
    Schachtel MJC; Gandhi M; Bowman JJ; Erian C; Porceddu SV; Panizza BJ
    ANZ J Surg; 2021 Jul; 91(7-8):1462-1471. PubMed ID: 33982375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic outcomes in primary squamous cell carcinoma of the auricle: a retrospective cohort analysis.
    Tanamal PJ; Geng CX; Nijhawan RI; Wynings E; Balachandra S; Myers LL; Tillman BN; Day AT
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):335-341. PubMed ID: 33956206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.
    Sood A; Bivona L; Mahkzoumi Z; Hausner P; Miller K; Regine WF; Snider J; Ng VY
    J Wound Care; 2020 Oct; 29(10):556-561. PubMed ID: 33052788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
    Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocyte cancer with incidental perineural invasion: A registry analysis of management and 5-year outcomes.
    Adams A; De'Ambrosis B; Panizza B; Belt P; Emmett J; Warren T; Whiteman DC
    Australas J Dermatol; 2020 Aug; 61(3):226-230. PubMed ID: 32285436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.
    Raza SM; Ramakrishna R; Weber RS; Kupferman ME; Gidley PW; Hanna EY; DeMonte F
    J Neurosurg; 2015 Sep; 123(3):781-8. PubMed ID: 25909577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auricular carcinoma with temporal bone invasion: outcome analysis.
    Gal TJ; Futran ND; Bartels LJ; Klotch DW
    Otolaryngol Head Neck Surg; 1999 Jul; 121(1):62-5. PubMed ID: 10388880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with recurrence of squamous cell carcinoma involving the temporal bone.
    McRackan TR; Fang TY; Pelosi S; Rivas A; Dietrich MS; Wanna GB; Labadie RF; Haynes DS; Bennett ML
    Ann Otol Rhinol Laryngol; 2014 Apr; 123(4):235-9. PubMed ID: 24671478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.